Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg

计划入组 23 人 · 首次发布于 2016 年 1 月 21 日

Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets

首次发布于 2012 年 7 月 6 日

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions

首次发布于 2012 年 7 月 6 日

OA-235c

PAR-401

PAR-1622

Par Pharmaceutical, Inc.

United States

PAR FORMULATIONS PRIVATE LIMITED

India

PersisGen Par Co.

Iran

Airway Therapeutics Strengthens Board with CorMedix CEO Joe Todisco as Zelpultide Alfa Advances

Par Health Launches Sugammadex Prefilled Syringe to Streamline Neuromuscular Blockade Reversal in Hospitals

Par Health Launches First and Only Generic Version of Janumet® XR in the United States